251 related articles for article (PubMed ID: 32184801)
61. [Pituitary tumor transforming gene 1 (PTTG1) is highly expressed and associated with poor prognosis in patients with hepatocellular carcinoma].
Tao H; Yang Y; Chen J; Lu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Apr; 36(4):337-343. PubMed ID: 32519672
[TBL] [Abstract][Full Text] [Related]
62. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
Cui Y; Zhou Z; Chai Y; Zhang Y
J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
[TBL] [Abstract][Full Text] [Related]
63. Integrated Bioinformatic Analysis Reveals the Oncogenic, Survival, and Prognostic Characteristics of TPX2 in Hepatocellular Carcinoma.
Zhang W; Dong J; Wu Y; Liang X; Suo L; Wang L
Biochem Genet; 2024 Jun; ():. PubMed ID: 38833082
[TBL] [Abstract][Full Text] [Related]
64. Co-regulatory Network of Oncosuppressor miRNAs and Transcription Factors for Pathology of Human Hepatic Cancer Stem Cells (HCSC).
Mohamed RH; Abu-Shahba N; Mahmoud M; Abdelfattah AMH; Zakaria W; ElHefnawi M
Sci Rep; 2019 Apr; 9(1):5564. PubMed ID: 30944375
[TBL] [Abstract][Full Text] [Related]
65. RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma.
Peng H; Zhu E; Wang J; Du X; Wang C; Yang M; Zhang Y
Front Pharmacol; 2022; 13():989655. PubMed ID: 36120364
[No Abstract] [Full Text] [Related]
66. Potential Role of NEU1 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis.
Wu Z; He L; Yang L; Fang X; Peng L
Front Mol Biosci; 2021; 8():651525. PubMed ID: 34513919
[No Abstract] [Full Text] [Related]
67. Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma.
Lv L; Zhao Y; Wei Q; Zhao Y; Yi Q
Cancer Cell Int; 2020; 20():210. PubMed ID: 32514254
[TBL] [Abstract][Full Text] [Related]
68. High mRNA Expression of
Cui Z; Xiao L; Chen F; Wang J; Lin H; Li D; Wu Z
Dis Markers; 2021; 2021():9971799. PubMed ID: 34457090
[TBL] [Abstract][Full Text] [Related]
69. DCK is an Unfavorable Prognostic Biomarker and Correlated With Immune Infiltrates in Liver Cancer.
Hu SF; Lin X; Xu LP; Chen HG; Guo JF; Jin L
Technol Cancer Res Treat; 2020; 19():1533033820934133. PubMed ID: 32588770
[TBL] [Abstract][Full Text] [Related]
70. Cell division cycle associated 8: A novel diagnostic and prognostic biomarker for hepatocellular carcinoma.
Cui XH; Peng QJ; Li RZ; Lyu XJ; Zhu CF; Qin XH
J Cell Mol Med; 2021 Dec; 25(24):11097-11112. PubMed ID: 34741389
[TBL] [Abstract][Full Text] [Related]
71. Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma.
Kim BH; Park JW; Kim JS; Lee SK; Hong EK
Gut Liver; 2019 May; 13(3):342-348. PubMed ID: 30600675
[TBL] [Abstract][Full Text] [Related]
72. SOX12 upregulation is associated with metastasis of hepatocellular carcinoma and increases CDK4 and IGF2BP1 expression.
Yuan P; Meng L; Wang N
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3821-3826. PubMed ID: 28975985
[TBL] [Abstract][Full Text] [Related]
73. Comprehensive analysis of the prognosis and immune infiltrates for the BET protein family reveals the significance of BRD4 in glioblastoma multiforme.
Ye Y; Zhong W; Qian J; Zhang J; Xu T; Han R; Han J; Wang C; Song L; Zeng X; Wang H
Front Cell Dev Biol; 2023; 11():1042490. PubMed ID: 36711038
[No Abstract] [Full Text] [Related]
74. Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma.
Jiang J; Liu B; Liu R; Yang W
Cancer Manag Res; 2021; 13():2517-2537. PubMed ID: 33758547
[TBL] [Abstract][Full Text] [Related]
75. Highly expressed centromere protein L indicates adverse survival and associates with immune infiltration in hepatocellular carcinoma.
Zeng Z; Jiang X; Pan Z; Zhou R; Lin Z; Tang Y; Cui Y; Zhang E; Cao Z
Aging (Albany NY); 2021 Oct; 13(19):22802-22829. PubMed ID: 34607313
[TBL] [Abstract][Full Text] [Related]
76. Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer.
Li L; Huang S; Yao Y; Chen J; Li J; Xiang X; Deng J; Xiong J
World J Surg Oncol; 2020 Dec; 18(1):324. PubMed ID: 33292276
[TBL] [Abstract][Full Text] [Related]
77. ALDH2 is a prognostic biomarker and related with immune infiltrates in HCC.
Yao S; Yin X; Chen T; Chen W; Zuo H; Bi Z; Zhang X; Jing Y; Pang L; Cheng H
Am J Cancer Res; 2021; 11(11):5319-5337. PubMed ID: 34873463
[TBL] [Abstract][Full Text] [Related]
78. TNFSF9 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Pancreatic Cancer.
Wu J; Wang Y; Jiang Z
J Gastrointest Cancer; 2021 Mar; 52(1):150-159. PubMed ID: 32077004
[TBL] [Abstract][Full Text] [Related]
79. CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma.
Lin T; Zhang E; Mai PP; Zhang YZ; Chen X; Peng LS
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34085699
[TBL] [Abstract][Full Text] [Related]
80. Stress Conditions Induced by Locoregional Therapies Stimulate Enrichment and Proliferation of Liver Cancer Stem Cells.
Huo Y; Chen WS; Lee J; Feng GS; Newton IG
J Vasc Interv Radiol; 2019 Dec; 30(12):2016-2025.e5. PubMed ID: 31208945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
